Evolution Mining Limited (ASX:EVN) Receives Approval for Cowal Operations Extension
Evolution Mining secures regulatory approval to extend Cowal Operations to 2042, enhancing local economic contributions.
Tag: Shareholder Updates
OpenLearning Limited Secures $2 Million Funding (ASX: OLL)
OpenLearning Limited raises $2 million through institutional placement and loan facility to bolster its growth strategy.
Orora Limited (ASX:ORA) Receives Regulatory Approvals for OPS Sale
Orora Limited (ASX:ORA) announces the successful regulatory approval for its OPS sale and plans an on-market share buyback post-completion.
Syntara Limited (ASX:SNT) Announces Positive Phase 2 Trial Results
Syntara Limited reports positive interim data from its Phase 2 trial of SNT-5505, indicating potential as a breakthrough treatment for myelofibrosis.
BrainChip Holdings Ltd (ASX:BRN) Secures US$1.8 Million Contract
BrainChip Holdings Ltd secures a US$1.8 million contract from the Air Force Research Laboratory for radar signal processing development.
OpenLearning Limited (ASX: OLL) Announces Voluntary Suspension
OpenLearning Limited (ASX: OLL) has announced a voluntary suspension of its securities pending a key announcement regarding a related party loan facility.
Korvest Ltd (ASX:KOV) Reports Record Order Book for FY25
Korvest Ltd (ASX:KOV) forecasts a record order book and increased project work expected to drive significant profits in FY25.
Korvest Ltd (ASX:KOV) Announces Pause in Trading
Korvest Ltd (ASX:KOV) has temporarily paused trading of its securities pending a further announcement.
Immutep Limited (ASX: IMM) Initiates Phase III Trial for Lung Cancer
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Integral Diagnostics (ASX: IDX) Provides Merger Update
Integral Diagnostics receives ACCC clearance for its merger with Capitol Health, expecting implementation by 20 December 2024.